201 related articles for article (PubMed ID: 19157592)
1. Patent foramen ovale in carcinoid heart disease.
Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
3. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
Hayashi Y; McGaw DJ; Goldstein J
Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
[TBL] [Abstract][Full Text] [Related]
4. Assessment of patent foramen ovale in carcinoid heart disease.
Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease.
Chaudhari PR; Abergel J; Warner RR; Zacks J; Love BA; Halperin JL; Adler E
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):455-9. PubMed ID: 17653118
[TBL] [Abstract][Full Text] [Related]
6. [Progressive dyspnoea in two patients with carcinoid syndrome].
Nölting S; Nicolaus M; Behr J; Baumgartner R; Mete H; Boekstegers P; Herrmann K; Theisen D; Lehrke M; Göke B; Schirra J; Auernhammer CJ
Internist (Berl); 2010 Nov; 51(11):1439-45. PubMed ID: 20628718
[TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
8. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery.
Douglas S; Oelofse T; Shah T; Rooney S; Arif S; Steeds RP
J Neuroendocrinol; 2023 Aug; 35(8):e13323. PubMed ID: 37580851
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
14. Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease.
Mottram PM; McGaw DJ; Meredith IT; Peverill RE; Harper RW
Eur J Echocardiogr; 2008 Jan; 9(1):47-9. PubMed ID: 17018264
[TBL] [Abstract][Full Text] [Related]
15. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic complications after pneumonectomy: atrial inflow obstruction and reopening of the foramen ovale.
Aigner C; Lang G; Taghavi S; Reza-Hoda MA; Marta G; Baumgartner H; Klepetko W
Eur J Cardiothorac Surg; 2008 Feb; 33(2):268-71. PubMed ID: 18061472
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of the patent foramen ovale.
Surmely JF; Meier B
Minerva Cardioangiol; 2007 Oct; 55(5):681-91. PubMed ID: 17912171
[TBL] [Abstract][Full Text] [Related]
18. Tricuspid and mitral valve carcinoid disease in the setting of a patent foramen ovale.
Mizuguchi KA; Fox AA; Burch TM; Cohn LH; Fox JA
Anesth Analg; 2008 Dec; 107(6):1819-21. PubMed ID: 19020123
[No Abstract] [Full Text] [Related]
19. Development of severe intrapulmonary shunting in a patient with carcinoid heart disease after closure of a persistent foramen ovale: a case report.
Schüttler D; Mourouzis K; Auernhammer CJ; Rizas KD
Eur Heart J Case Rep; 2021 Dec; 5(12):ytab494. PubMed ID: 35047738
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders.
Thaman R; Faganello G; Gimeno JR; Szantho GV; Nelson M; Curtis S; Martin RP; Turner MS
Heart; 2011 Mar; 97(5):394-9. PubMed ID: 21296783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
